Rosenthal, Eric T.
Ohio State University President E. Gordon Gee, PhD, finally made public earlier this month the restructuring of the university's cancer center leadership, a move calculated to “allow it to move swiftly toward its goal of becoming a top 10 National Cancer Institute-funded program and to focus efforts on planned expansion of the Ohio State Medical Center,” according to a university press release.
The consolidation (OT, 12/25/07), should strengthen the freestanding-within-matrix cancer center model, and keep the Ohio State University Comprehensive Cancer Center (OSUCCC) in compliance with the Centers for Medicare & Medicaid Service's prospective payment system (PPS) exemption.
Michael Caligiuri, MD, who had been OSUCCC Director, will continue in that role and will succeed David Schuller, MD, as CEO of the James Cancer Hospital and Solove Research Institute. Dr. Schuller had been Senior Executive Director and Dr. Caligiuri was Deputy Director. Dr. Caligiuri is also the John L. Marakas Nationwide Insurance Enterprise Foundation Chair in Cancer Research, and Professor of Medicine at OSU, as well as President-elect of the Association of American Cancer Institutes.
He will report to Dr. Gee with responsibility for all administrative, financial, and operational aspects of the James, and report to Joseph Alutto, PhD—the university's Executive Vice President and Provost—in his capacity as director of the comprehensive cancer center—a relationship that will no longer have him reporting through the Medical Center structure.
Dr. Schuller has been appointed Vice President for Medical Center Expansion and Outreach by Wiley “Chip” Souba Jr., MD, ScD, MBA, Interim Senior Vice President and Executive Dean for Health Sciences and CEO of the Medical Center, and will continue as Medical Director of the Medical Center's development campaign, and as a member of its master facilities executive planning team.
He was also named CEO Emeritus of the James, and Director Emeritus of the Comprehensive Cancer Center, which he directed from 1977 to 1998.
Dr. Caligiuri told OT in a telephone interview following the announcement that OSUCCC's strategic plan, vision, and goals will remain as they were, and the change will allow Dr. Schuller to oversee Project Cancer, as well as the medical center's $1 billion expansion, of which half will be for cancer.
Dennis J. Smith, MBA, who was Executive Director of the James, has been named the cancer hospital's Chief Operating Officer. He is also Chairman of the Alliance of Dedicated Cancer Centers, an alliance of the 10 PPS-exempt cancer centers.
© 2008 Lippincott Williams & Wilkins, Inc.